Company intelligence / Profile preview

FzioMed

San Luis Obispo, California, United Statesfziomed.com ↗

Ownership: Private
Employees: ~38
Development stage: Commercial

Overview

FzioMed’s synthetic absorbable gel formulations based on its patented dual-polymer technology provide a temporary physical barrier to reduce the formation of surgical adhesions. These products have demonstrated proven safety and clinical efficacy in nearly one million procedures worldwide since their introduction in 2002. They are marketed in over 70 countries for various surgical applications including spine and gynecology.

Therapeutic areas: OtherRheumatologyGastroenterologyNeurologyWomen's Health
Modalities: DeviceHydrogel-based drug delivery therapyPolymer-drug conjugate therapy
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

Dynavisc

Commercial

Indications: Tendon surgery adhesions, Peripheral nerve surgery adhesions

1 more asset in the full pipeline.

Beyond the preview

Go deeper on FzioMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FzioMed.